What is PharmaCyte Biotech Inc (PMCB) stock price today?

PharmaCyte Biotech Inc (PMCB) currently trades at $0.75 per share. The stock has a market capitalization of $8.05M and a P/E ratio of —x.

Is PMCB stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, PharmaCyte Biotech Inc has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

PMCB

PharmaCyte Biotech Inc

NASDAQ: PMCB · HEALTHCARE · BIOTECHNOLOGY

$0.75

-1.32% today

Updated 2026-04-29

Market cap

$8.05M

P/E ratio

—

P/S ratio

12,904.41x

EPS (TTM)

$-0.89

Dividend yield

—

52W range

$1 – $2

Volume

0.1M

Market cap

$8.05M

P/E ratio

—

P/S ratio

12,904.41x

EPS (TTM)

$-0.89

Dividend yield

—

52W range

$1 – $2

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.3

Quality

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$—

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-786848.00

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-4.24M	$-4.32M	$333763.00	$30.66M	$746860.00
EPS	—	—	—	—	$-0.89
Free cash flow	$-4.12M	$-3.79M	$-2.15M	$-2.98M	$-786848.00
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PMCB	$8.05M	26	4.3	3.0	5.0	6.3	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

PharmaCyte Biotech Inc trades at $0.75. Our Smart Value Score of 26/100 indicates the stock is weak.

Frequently asked questions

What is PharmaCyte Biotech Inc's stock price?

PharmaCyte Biotech Inc (PMCB) trades at $0.75.

Is PharmaCyte Biotech Inc overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of PharmaCyte Biotech Inc (PMCB)?

The analyst target price is $—, representing NaN% downside from the current price of $0.75.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio12,904.41x

ROE-8.24%

Beta0.41

50D MA$0.71

200D MA$0.86

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

PMCB vs LLY →PMCB vs JNJ →PMCB vs ABBV →Stock screener →